From September 1, 2023 to November 30, 2023, the company has repurchased 1,356,000 shares, representing 1.75% for ¥6,806.73 million. With this, the company has completed the repurchase of 1,633,400 shares, representing 2.11% for ¥8,140.32 million under the buyback announced on July 13, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,740 JPY | -2.07% | -1.06% | -13.25% |
Apr. 11 | Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024 | MT |
Jan. 12 | Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.25% | 1.84B | |
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |
- Stock Market
- Equities
- 4530 Stock
- News Hisamitsu Pharmaceutical Co., Inc.
- Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.